Verve Therapeutics (VERV) shares jumped about 24% in recent Tuesday trading after Cantor Fitzgerald upgraded the stock to overweight from neutral.
Trading volume reached over 21.1 million shares versus a daily average of more than 2.1 million.
Price: 5.09, Change: +0.97, Percent Change: +23.54